Csenge Advisory Group

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1715593 CLEARWATER, FL

Position in VRTX

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$253,829

-$14,541 QoQ

Shares Held

511

-15.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#1,302

of 1,735 holders

Holding Since

Sep 2022

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Csenge Advisory Group holds $2,906,060 across 6 Biotechnology names. VRTX ranks #5 (8.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	5,037	$1,213,765
2	ASND	Ascendis Pharma A/S	2,171	$579,049
3	AXSM	Axsome Therapeutics, Inc.	2,067	$505,939
4	RPRX	Royalty Pharma plc	5,951	$333,672
5	VRTX	Vertex Pharmaceuticals Inc / Ma This page	511	$253,829
6	GERN	Geron Corp	15,474	$19,806

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$253,829	511	-15.0%	Shares	Sole	2026-08-10
2026-03-31	$268,370	601	-61.9%	Shares	Sole	2026-04-30
2025-12-31	$714,495	1,576	-12.1%	Shares	Sole	2026-02-06
2025-09-30	$701,818	1,792	-14.5%	Shares	Sole	2025-10-28
2025-06-30	$933,139	2,096	-3.9%	Shares	Sole	2025-08-06
2025-03-31	$1,057,392	2,181	+1.7%	Shares	Sole	2025-05-05
2024-12-31	$863,388	2,144	-27.9%	Shares	Sole	2025-01-30
2024-09-30	$1,382,217	2,972	-12.6%	Shares	Sole	2024-11-13
2024-06-30	$1,594,585	3,402	+23.1%	Shares	Sole	2024-07-10
2024-03-31	$1,155,379	2,764	+10.3%	Shares	Sole	2024-05-03
2023-12-31	$1,019,666	2,506	+21.2%	Shares	Sole	2024-02-13
2023-09-30	$718,778	2,067	+5.8%	Shares	Sole	2023-11-01
2023-06-30	$687,280	1,953	+12.9%	Shares	Sole	2023-07-20
2023-03-31	$545,071	1,730	+24.6%	Shares	Sole	2023-05-01
2022-12-31	$400,826	1,388	+14.7%	Shares	Sole	2023-02-10
2022-09-30	$350,343	1,210	—	Shares	Sole	2022-10-04
No filing history on record for this holder in this stock.